X Kai, TU Xiao-Yan, LIU Miao, ZW Liang… - Chinese Journal of …, 2021 - ncbi.nlm.nih.gov
… This study evaluated the safety and effectiveness of the COVID-19 vaccine through systematic literature review and qualitative analysis for the published COVID-19 vaccine clinical trial …
C Cai, Y Peng, E Shen, Q Huang, Y Chen, P Liu… - Molecular Therapy, 2021 - cell.com
… efficacy and safety of COVID-19 vaccines using published clinical trial data and real-world data. We comprehensively analyzed the efficacy of the existing COVID-19 … that the efficacy of …
RL Soiza, C Scicluna, EC Thomson - Age and ageing, 2021 - academic.oup.com
… coronavirus disease 2019 (COVID-19) are on the cusp of regulatory approval. Their safety and efficacy … , with strong antibody responses and reassuring safety profiles but, with the …
PT Heath, EP Galiza, DN Baxter, M Boffito… - … England Journal of …, 2021 - Mass Medical Soc
… These new variants may threaten our current attempts at controlling Covid-19 and lead to … evaluate the efficacy, immunogenicity, and safety of NVX-CoV2373 in preventing Covid-19 in …
FP Polack, SJ Thomas, N Kitchin… - New England journal …, 2020 - Mass Medical Soc
… Here, we report safety and efficacy findings from the phase 2/3 part of a global phase 1/2/3 … the safety, immunogenicity, and efficacy of 30 μg of BNT162b2 in preventing Covid-19 in …
… BNT162b2 had a favorable safety … Safety, efficacy, and immunogenicity data from participants 12 to 15 years of age in this trial have been reported. Here, we report safety and efficacy …
… ’ safety, efficacy, and immunogenicity against SARS-CoV-2. Here, we mainly focused on available RCTs publications on the safety, efficacy, and immunogenicity of COVID-19 vaccines. …
L Dai, L Gao, L Tao, SR Hadinegoro… - New England journal …, 2022 - Mass Medical Soc
… The results of clinical studies of the efficacy of Covid-19 … protein were shown to have an efficacy of 90 to 96%. These … been widely used as the Covid-19 vaccine target (four vaccines …
… efficacy and safety of coronavirus disease 2019 (COVID-19) vaccines. This study analyzed the efficacy of COVID-19 … Published phase I, phase II, and phase III trials analyzing safety and …